(Q34229628)

English

Buruli ulcer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Buruli ulcer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Thorbjorg Einarsdottir

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1198-1203

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

A major role for mammals in the ecology of Mycobacterium ulcerans.

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR.

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Application of real-time PCR in Ghana, a Buruli ulcer-endemic country, confirms the presence of Mycobacterium ulcerans in the environment

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

BCG-mediated protection against Mycobacterium ulcerans infection in the mouse

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Chemistry of mycolactones, the causative toxins of Buruli ulcer

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism.

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Evidence for an intramacrophage growth phase of Mycobacterium ulcerans

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Buruli ulcer disease: prospects for a vaccine

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Use of the immunodominant 18-kilodalton small heat shock protein as a serological marker for exposure to mycobacterium ulcerans

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Prospects for vaccine development against Buruli disease

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Persistent association of Mycobacterium ulcerans with West African predaceous insects of the family belostomatidae

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Epidemiology of Buruli ulcer in Amansie West district, Ghana

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Humoral response against Mycobacterium bovis Hsp65 derived fragments in children and young people with various disorders

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Independent loss of immunogenic proteins in Mycobacterium ulcerans suggests immune evasion.

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Aquatic invertebrates as unlikely vectors of Buruli ulcer disease

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Histopathologic features of Mycobacterium ulcerans infection

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.11.17751

21 January 2018

Identifiers

10.4161/HV.7.11.17751

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34229628&oldid=1543547377"